Loading…
Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)
Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among h...
Saved in:
Published in: | BMC infectious diseases 2017-09, Vol.17 (1), p.614-614, Article 614 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23 |
---|---|
cites | cdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23 |
container_end_page | 614 |
container_issue | 1 |
container_start_page | 614 |
container_title | BMC infectious diseases |
container_volume | 17 |
creator | He, Xiaoguang Xie, Mingyu Li, Siping Ye, Junqin Peng, Qi Ma, Qiang Lu, Xiaomei Zhong, Baimao |
description | Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China.
Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance.
Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria.
S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China. |
doi_str_mv | 10.1186/s12879-017-2710-4 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7128d55ebf5a4887ad9bcc15fbe8750a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A509101266</galeid><doaj_id>oai_doaj_org_article_7128d55ebf5a4887ad9bcc15fbe8750a</doaj_id><sourcerecordid>A509101266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</originalsourceid><addsrcrecordid>eNqNkstu1DAUhiMEoqXwAGyQJTatRIrt3OwN0mi4jVSpEret5dhOxqPEntoOZXgf3pMTppQOYoGycHT8nd8-v_8se0rwOSGsfhkJZQ3PMWly2hCcl_eyY1I2JKdFUd6_83-UPYpxgwFklD_MjihjvCC8Os5-LFyyo1XBt1YOKJhoY5JOGWQdaqVKJsz1rUxr3xsXkRy969Hax61NcrDfjUZqbQcdjEPXNq2R8uM4OZt2SKqryQYABn9twqy9tUEmH3YoBZCGIzqjkvUgC6e9BuF-ku4FWq6tk-iUYgLXx6Q-e5w96OQQzZOb9ST7_PbNp-X7_OLy3Wq5uMhVTVnKqS4wJQVnJa5ZUROjy5Z2GuZmdadZo7hiVHHDu5aVda3bmpZUt6ToOC6ZosVJttrrai83YhvsKMNOeGnFr4IPvZAhWTUY0YD3uqpM21WyZKyRmrdKkaprDWsqLEHr1V5rO7Wj0co4GHo4ED3ccXYtev9VVBUvKzxf5vRGIPirycQkRhuVGQbpjJ-iILxghPOSlIA-_wvd-Ck4sAooEOMVw-QP1UsYAMz38zPMomIBDMGE1jVQ5_-g4NMGcuKd6SzUDxrODhqASeZb6uUUo1h9_PD_7OWXQ5bsWQhnjMF0t94RLOb8i33-BcRazPkXsxHP7pp-2_E78MVPT3L_cA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1945095801</pqid></control><display><type>article</type><title>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>He, Xiaoguang ; Xie, Mingyu ; Li, Siping ; Ye, Junqin ; Peng, Qi ; Ma, Qiang ; Lu, Xiaomei ; Zhong, Baimao</creator><creatorcontrib>He, Xiaoguang ; Xie, Mingyu ; Li, Siping ; Ye, Junqin ; Peng, Qi ; Ma, Qiang ; Lu, Xiaomei ; Zhong, Baimao</creatorcontrib><description>Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China.
Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance.
Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria.
S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-017-2710-4</identifier><identifier>PMID: 28893195</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Abuse ; Analysis ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotic resistance ; Antibiotics ; Antiinfectives and antibacterials ; Antimicrobial agents ; Antimicrobial resistance ; Bacteria ; Bacterial Infections - drug therapy ; Bacterial Infections - epidemiology ; Bacterial Infections - microbiology ; Carbapenems ; Cephalosporins ; Child, Hospitalized - statistics & numerical data ; Child, Preschool ; Children ; China - epidemiology ; Chlamydia ; Chlamydia pneumoniae ; Clinical medicine ; Communities ; Community-Acquired Infections - drug therapy ; Community-Acquired Infections - epidemiology ; Community-Acquired Infections - microbiology ; Diffusion tests ; Drug resistance ; Drug Resistance, Bacterial - drug effects ; E coli ; Epidemiology ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli - isolation & purification ; Female ; Fluoroquinolones ; Health risks ; Hospitals ; Humans ; Infant ; Infant, Newborn ; Infants ; Infections ; Infectious diseases ; Intensive care ; Klebsiella pneumoniae ; Laboratories ; Male ; Microbial Sensitivity Tests ; Mycoplasma pneumoniae ; Pathogens ; Pediatrics ; Pneumonia ; Pseudomonas aeruginosa ; Respiratory tract ; Respiratory tract diseases ; Respiratory tract infection ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Retrospective Studies ; Sputum ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation & purification ; Streptococcus ; Streptococcus infections ; Streptococcus pneumoniae ; Vancomycin</subject><ispartof>BMC infectious diseases, 2017-09, Vol.17 (1), p.614-614, Article 614</ispartof><rights>COPYRIGHT 2017 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2017</rights><rights>The Author(s). 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</citedby><cites>FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594502/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1945095801?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28893195$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Xiaoguang</creatorcontrib><creatorcontrib>Xie, Mingyu</creatorcontrib><creatorcontrib>Li, Siping</creatorcontrib><creatorcontrib>Ye, Junqin</creatorcontrib><creatorcontrib>Peng, Qi</creatorcontrib><creatorcontrib>Ma, Qiang</creatorcontrib><creatorcontrib>Lu, Xiaomei</creatorcontrib><creatorcontrib>Zhong, Baimao</creatorcontrib><title>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China.
Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance.
Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria.
S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China.</description><subject>Abuse</subject><subject>Analysis</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antiinfectives and antibacterials</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Bacteria</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - epidemiology</subject><subject>Bacterial Infections - microbiology</subject><subject>Carbapenems</subject><subject>Cephalosporins</subject><subject>Child, Hospitalized - statistics & numerical data</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>China - epidemiology</subject><subject>Chlamydia</subject><subject>Chlamydia pneumoniae</subject><subject>Clinical medicine</subject><subject>Communities</subject><subject>Community-Acquired Infections - drug therapy</subject><subject>Community-Acquired Infections - epidemiology</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Diffusion tests</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>E coli</subject><subject>Epidemiology</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - isolation & purification</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Health risks</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Intensive care</subject><subject>Klebsiella pneumoniae</subject><subject>Laboratories</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Mycoplasma pneumoniae</subject><subject>Pathogens</subject><subject>Pediatrics</subject><subject>Pneumonia</subject><subject>Pseudomonas aeruginosa</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Respiratory tract infection</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Retrospective Studies</subject><subject>Sputum</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Streptococcus</subject><subject>Streptococcus infections</subject><subject>Streptococcus pneumoniae</subject><subject>Vancomycin</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkstu1DAUhiMEoqXwAGyQJTatRIrt3OwN0mi4jVSpEret5dhOxqPEntoOZXgf3pMTppQOYoGycHT8nd8-v_8se0rwOSGsfhkJZQ3PMWly2hCcl_eyY1I2JKdFUd6_83-UPYpxgwFklD_MjihjvCC8Os5-LFyyo1XBt1YOKJhoY5JOGWQdaqVKJsz1rUxr3xsXkRy969Hax61NcrDfjUZqbQcdjEPXNq2R8uM4OZt2SKqryQYABn9twqy9tUEmH3YoBZCGIzqjkvUgC6e9BuF-ku4FWq6tk-iUYgLXx6Q-e5w96OQQzZOb9ST7_PbNp-X7_OLy3Wq5uMhVTVnKqS4wJQVnJa5ZUROjy5Z2GuZmdadZo7hiVHHDu5aVda3bmpZUt6ToOC6ZosVJttrrai83YhvsKMNOeGnFr4IPvZAhWTUY0YD3uqpM21WyZKyRmrdKkaprDWsqLEHr1V5rO7Wj0co4GHo4ED3ccXYtev9VVBUvKzxf5vRGIPirycQkRhuVGQbpjJ-iILxghPOSlIA-_wvd-Ck4sAooEOMVw-QP1UsYAMz38zPMomIBDMGE1jVQ5_-g4NMGcuKd6SzUDxrODhqASeZb6uUUo1h9_PD_7OWXQ5bsWQhnjMF0t94RLOb8i33-BcRazPkXsxHP7pp-2_E78MVPT3L_cA</recordid><startdate>20170911</startdate><enddate>20170911</enddate><creator>He, Xiaoguang</creator><creator>Xie, Mingyu</creator><creator>Li, Siping</creator><creator>Ye, Junqin</creator><creator>Peng, Qi</creator><creator>Ma, Qiang</creator><creator>Lu, Xiaomei</creator><creator>Zhong, Baimao</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170911</creationdate><title>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</title><author>He, Xiaoguang ; Xie, Mingyu ; Li, Siping ; Ye, Junqin ; Peng, Qi ; Ma, Qiang ; Lu, Xiaomei ; Zhong, Baimao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abuse</topic><topic>Analysis</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antiinfectives and antibacterials</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Bacteria</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - epidemiology</topic><topic>Bacterial Infections - microbiology</topic><topic>Carbapenems</topic><topic>Cephalosporins</topic><topic>Child, Hospitalized - statistics & numerical data</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>China - epidemiology</topic><topic>Chlamydia</topic><topic>Chlamydia pneumoniae</topic><topic>Clinical medicine</topic><topic>Communities</topic><topic>Community-Acquired Infections - drug therapy</topic><topic>Community-Acquired Infections - epidemiology</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Diffusion tests</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>E coli</topic><topic>Epidemiology</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - isolation & purification</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Health risks</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Intensive care</topic><topic>Klebsiella pneumoniae</topic><topic>Laboratories</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Mycoplasma pneumoniae</topic><topic>Pathogens</topic><topic>Pediatrics</topic><topic>Pneumonia</topic><topic>Pseudomonas aeruginosa</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Respiratory tract infection</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Retrospective Studies</topic><topic>Sputum</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Streptococcus</topic><topic>Streptococcus infections</topic><topic>Streptococcus pneumoniae</topic><topic>Vancomycin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Xiaoguang</creatorcontrib><creatorcontrib>Xie, Mingyu</creatorcontrib><creatorcontrib>Li, Siping</creatorcontrib><creatorcontrib>Ye, Junqin</creatorcontrib><creatorcontrib>Peng, Qi</creatorcontrib><creatorcontrib>Ma, Qiang</creatorcontrib><creatorcontrib>Lu, Xiaomei</creatorcontrib><creatorcontrib>Zhong, Baimao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints (Gale)</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Xiaoguang</au><au>Xie, Mingyu</au><au>Li, Siping</au><au>Ye, Junqin</au><au>Peng, Qi</au><au>Ma, Qiang</au><au>Lu, Xiaomei</au><au>Zhong, Baimao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016)</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2017-09-11</date><risdate>2017</risdate><volume>17</volume><issue>1</issue><spage>614</spage><epage>614</epage><pages>614-614</pages><artnum>614</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Bacterial pathogens are a major cause of childhood community acquired lower respiratory tract infections (CA-LRTIs), and few data described the impact of antimicrobial resistance on children with CA-LRTIs. This study aims to investigate the antimicrobial resistance in common bacterial agents among hospitalized children with CA-LRTIs between 2011 and 2016 in Dongguan, China.
Sputum samples were collected from hospitalized children (0-5 years old) with CA-LRTIs in Dongguan Children's Hospital. Bacterial pathogens were detected using traditional culture methods, and disc diffusion tests were used to determine antibiotic resistance.
Among the 2360 samples analyzed, 342 (14.5%) were positive for bacterial infection. The most prevalent pathogen was MSSA (2.3%), followed by MRSA (1.5%), E. coli (1.7%), E. coli ESBLs (1.2%), K. pneumonia ESBLs (1.5%), K. pneumonia (1.4%) and S. pneumonia (1.3%). Of the hospitalized patients with bacteria causing of CA-LRTIs, 90.1% were less than 1-year-old. MSSA and MRSA were more commonly isolated in infants less than 3 months. E. coli, K. pneumonia and K. pneumonia ESBLs were more common bacteria causing CA-LRTIs in infants less than 1 month. Resistance levels to penicillins, fluoroquinolones, macrolides, cephalosporins, carbapenems and vancomycin varied in different bacteria.
S. aureus, E coli and K. pneumonia were the common bacterial isolates recovered from chidren with CA-LTRIs during 2011-2015. Age group of under 1 year old was at a high risk of bacterial infections. Many isolates showed antibiotic resistance level was associated with antibiotic usage in clinic. Increasing surveillance of antibiotic resistance is urgently needed and develops better strategies to cure the antibiotic abuse in China.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>28893195</pmid><doi>10.1186/s12879-017-2710-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2334 |
ispartof | BMC infectious diseases, 2017-09, Vol.17 (1), p.614-614, Article 614 |
issn | 1471-2334 1471-2334 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_7128d55ebf5a4887ad9bcc15fbe8750a |
source | Publicly Available Content Database; PubMed Central |
subjects | Abuse Analysis Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotic resistance Antibiotics Antiinfectives and antibacterials Antimicrobial agents Antimicrobial resistance Bacteria Bacterial Infections - drug therapy Bacterial Infections - epidemiology Bacterial Infections - microbiology Carbapenems Cephalosporins Child, Hospitalized - statistics & numerical data Child, Preschool Children China - epidemiology Chlamydia Chlamydia pneumoniae Clinical medicine Communities Community-Acquired Infections - drug therapy Community-Acquired Infections - epidemiology Community-Acquired Infections - microbiology Diffusion tests Drug resistance Drug Resistance, Bacterial - drug effects E coli Epidemiology Escherichia coli Escherichia coli - drug effects Escherichia coli - isolation & purification Female Fluoroquinolones Health risks Hospitals Humans Infant Infant, Newborn Infants Infections Infectious diseases Intensive care Klebsiella pneumoniae Laboratories Male Microbial Sensitivity Tests Mycoplasma pneumoniae Pathogens Pediatrics Pneumonia Pseudomonas aeruginosa Respiratory tract Respiratory tract diseases Respiratory tract infection Respiratory Tract Infections - drug therapy Respiratory Tract Infections - microbiology Retrospective Studies Sputum Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - isolation & purification Streptococcus Streptococcus infections Streptococcus pneumoniae Vancomycin |
title | Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A12%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20resistance%20in%20bacterial%20pathogens%20among%20hospitalized%20children%20with%20community%20acquired%20lower%20respiratory%20tract%20infections%20in%20Dongguan,%20China%20(2011-2016)&rft.jtitle=BMC%20infectious%20diseases&rft.au=He,%20Xiaoguang&rft.date=2017-09-11&rft.volume=17&rft.issue=1&rft.spage=614&rft.epage=614&rft.pages=614-614&rft.artnum=614&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-017-2710-4&rft_dat=%3Cgale_doaj_%3EA509101266%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c628t-2d30213984068361ed4b2fd00186fd87c9c82c9e9fb8466db6242db13f9048c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1945095801&rft_id=info:pmid/28893195&rft_galeid=A509101266&rfr_iscdi=true |